Erlotinib is effective against FLT3-ITD mutant AML and helps to overcome intratumoral heterogeneity via targeting FLT3 and Lyn

Cao, ZX; Guo, CJ; Song, XMT; He, JL; Tan, L; Yu, S; Zhang, RQ; Peng, F; Peng, C; Li, YZ

Peng, C; Li, YZ (corresponding author), Chengdu Univ Tradit Chinese Med, Coll Pharm, 1166 Liutai Rd, Chengdu 611137, Sichuan, Peoples R China.

FASEB JOURNAL, 2020; 34 (8): 10182

Abstract

Erlotinib has potential therapeutic effect on acute myeloid leukemia (AML) in patients, but the mechanism is not clear. Effective tumor biomarkers for......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索